Cartagena Protocol on Biosafety | Community Health

The Cartagena Protocol on Biosafety is an international agreement that aims to ensure the safe handling, transport, and use of living modified organisms (LMOs) resulting from modern biotechnology. Adopted on January 29, 2000, and entered into force on September 11, 2003, the protocol has 173 parties, including the European Union. The protocol is a supplement to the Convention on Biological Diversity (CBD) and focuses on the potential risks of LMOs to the environment and human health. The protocol establishes a framework for the transboundary movement of LMOs, including risk assessment, risk management, and informed consent procedures. The Cartagena Protocol has been influential in shaping national biosafety regulations and has been the subject of controversy, with some arguing that it hinders the development of genetically modified crops, while others see it as essential for protecting the environment and public health. With a vibe score of 6, the protocol is a significant but not highly polarizing topic, reflecting the complex and nuanced nature of the debate surrounding genetically modified organisms.